5 Implementation

5 Implementation

5.1 The Secretary of State has directed that the NHS provides funding and resources for medicines and treatments that have been recommended by NICE technology appraisals normally within 3 months of the guidance being published. If the Department of Health issues a variation to the 3-month funding direction, details will be available on the NICE website.

5.2 The Welsh Assembly Minister for Health and Social Services issued a direction in October 2003 that requires local health boards and NHS trusts to make funding available to implement NICE technology appraisal guidance, normally within 3 months of the guidance being published.

5.3 When NICE recommends a treatment 'as an option', the NHS must make sure it is available within the period set out in the paragraph above. This means that, if a patient has multiple myeloma and has received at least two or more prior therapies and the doctor responsible for their care thinks that lenalidomide is the right treatment, it should be available for use, in line with NICE's recommendations.

5.4 NICE has developed tools to help organisations implement this guidance (listed below).

  • Costing report and costing template to estimate the savings and costs associated with implementation.

  • Audit support for monitoring local practice.

  • National Institute for Health and Care Excellence (NICE)